Therapeutic effect of allicin in a mouse model of intracerebral hemorrhage

J Pharmacol Sci. 2023 Dec;153(4):208-214. doi: 10.1016/j.jphs.2023.09.007. Epub 2023 Oct 2.

Abstract

Natural compounds with sulfur moiety produce various biological actions that may be beneficial for the therapies of several devastative disorders of the central nervous system. Here we investigated potential therapeutic effect of allicin, an organosulfur compound derived from garlic, in a mouse model of intracerebral hemorrhage (ICH) based on intrastriatal collagenase injection. Daily intraperitoneal administration of allicin (50 mg/kg) from 3 h after induction of ICH afforded neuroprotective effects, as evidenced by the increase of surviving neurons in the hematoma, reduction of axonal transport impairment, and prevention of axon tract injury. In addition, allicin inhibited accumulation of activated microglia/macrophages around the hematoma and infiltration of neutrophils within the hematoma. Allicin also suppressed ICH-induced mRNA upregulation of pro-inflammatory factors such as interleukin 6 and C-X-C motif ligand 2 in the brain, suggesting its anti-inflammatory effect. Moreover, ICH-induced increase of malondialdehyde as well as decrease of total glutathione in the brain was attenuated by allicin. Finally, allicin-treated mice showed better recovery of sensorimotor functions after ICH than vehicle-treated mice. These results indicate that allicin produces a therapeutic effect on ICH pathology via alleviation of neuronal damage, inflammatory responses and oxidative stress in the brain.

Keywords: Hemorrhagic stroke; Neuroinflammation; Neuroprotection; Organosulfur; Sensorimotor function.

MeSH terms

  • Animals
  • Brain* / pathology
  • Cerebral Hemorrhage* / drug therapy
  • Hematoma / pathology
  • Mice
  • Microglia / pathology

Substances

  • allicin